Glucagon-like peptide-1 receptor agonists and muscle mass effects
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have transformed the management of obesity, demonstrating significant efficacy in inducing weight loss and improving metabolic parameters. However, emerging clinical and paraclinical evidence suggests that these agents may also contribute to an u...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2025-10-01
|
| Reeks: | Pharmacological Research |
| Onderwerpen: | |
| Online toegang: | http://www.sciencedirect.com/science/article/pii/S1043661825003524 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
